Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Quantity Surveying and Construction Management department aspires to excellence
2017-08-14

Description: Prof Kahilu Kajimo-Shakantu Tags: Prof Kahilu Kajimo-Shakantu 

From the left: Prof Danie Vermeulen, Dean of the
Faculty of Natural and Agricultural Sciences;
Prof Kahilu Kajimo-Shakantu, Head of the Department
of Quantity Surveying and Construction Management;
Prof Francis Petersen, Rector and Vice-Chancellor
at the UFS; and Dr Franco Geminiani, chairing the
panel from the South African Council for the Project
and Construction Management Professions.
Photo: Leonie Bolleurs

Achieving programme accreditation from the respective professional bodies is the ultimate goal for the Department of Quantity Surveying and Construction Management at the University of the Free State (UFS). This is according to Prof Kahilu Kajimo-Shakantu, the head of this department. This hallmark of quality reflects the university’s aspiration towards excellence.

Construction Management programmes reviewed
The university recently received a visit by a panel, representing the South African Council for the Project and Construction Management Professions (SACPCMP) to re-accredit programmes offered by the Department of Quantity Surveying and Construction Management. During the accreditation visit, the panel evaluated the programmes to determine whether they met the minimum requirements according to a set of pre-determined criteria.

When reviewing the programmes: BSc and BSc Hons Construction Management respectively, as well as the Project Management stream of the Masters programme in Land and Property Development Management (MLPM), the panel looked at programme design and outcomes including curriculum, study material and exam papers, institutional support, student recruitment, admission, development, retention and throughput, staffing recruitment and development, teaching and learning strategies, quality assurance, facilities, infrastructure and resources, professional development, industry and practical exposure and postgraduate policies, procedures and regulations, including research activities.

If the minimum requirements are achieved, the Department of Quantity Surveying and Construction Management at the UFS will receive accreditation for its programmes from 1 April 2017 to 31 March 2022.

It will also mean that we are certified
as producing quality employable
graduates who are well prepared to
enter the industry and make a difference.

Currently, the department has full accreditation by the SACPCMP (until March 2017) and the SACQSP (until December 2017).

Later this month, a panel from the South African Council for Property Valuation Profession (SACPVP) will review the accreditation of the Valuation stream of the MLPM programme. The South African Council for Quantity Surveying Profession responsible for accrediting the Quantity Surveying programmes will visit the university in 2018.

Certified as producing quality students

Prof Kajimo-Shakantu said: “If we maintain our accreditation, it will reflect that the UFS is among the best, with programmes which are recognised by professional bodies that set competence standards for professional registration of students. It will also mean that we are certified as producing quality employable graduates who are well prepared to enter the industry and make a difference. The programmes contribute to the development of the much-needed critical skills in the built environment.”


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept